GRIFOLS SA INH. A EO-,25/ ES0171996087 /
| 2024-04-24 8:05:21 AM | Chg. -0.186 | Volume | Bid10:00:01 PM | Ask10:00:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 8.424EUR | -2.16% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 6.9 bill.EUR | - | 93.07 |
GlobeNewswire
04-18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
04-04
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
2023-11-15
Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous ...
